These hub genes, particularly BCL-2, GSK3B, MAO-B, and MAO-A are critical players in the network as indicated by their topological metrics highlighting their central roles in apoptosis regulation, dopamine metabolism, and neuroprotection, underscoring the molecular mechanisms through which resveratrol might exert its beneficial effects in Parkinson’s disease. This evidence concerns the gene GSK3B and Parkinson disease.